Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer.

Marta De Donato; Marisa Mariani; Lella Petrella; Enrica Martinelli; Gian Franco Zannoni; Valerio Vellone; Gabriella Ferrandina; Shohreh Shahabi; Giovanni Scambia; Cristiano Ferlini

doi:10.1002/jcp.22813

Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer.

Identifier:nobleid.org/w1/20260515/D97124F9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D97124F9.svg?ark=w1%2F20260515%2FD97124F9)](https://nobleid.org/work/w1/20260515/D97124F9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer.

Identifier:nobleid.org/w1/20260515/D97124F9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D97124F9.svg?ark=w1%2F20260515%2FD97124F9)](https://nobleid.org/work/w1/20260515/D97124F9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work